These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 3440748

  • 1. Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO).
    Rapoport J, Chaimovitz C, Abulfil A, Mostovlavsky M, Gazit D, Bab I.
    Isr J Med Sci; 1987 Dec; 23(12):1242-6. PubMed ID: 3440748
    [Abstract] [Full Text] [Related]

  • 2. Aluminum-related osteomalacia in renal-failure patients.
    Vick KE, Johnson CA.
    Clin Pharm; 1985 Dec; 4(4):434-9. PubMed ID: 3899471
    [Abstract] [Full Text] [Related]

  • 3. Changes in bone histology after treatment with desferrioxamine.
    Ott SM, Andress DL, Nebeker HG, Milliner DS, Maloney NA, Coburn JW, Sherrard DJ.
    Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986
    [No Abstract] [Full Text] [Related]

  • 4. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?
    Hodsman AB, Hood SA, Brown P, Cordy PE.
    J Lab Clin Med; 1985 Dec; 106(6):674-81. PubMed ID: 4067379
    [Abstract] [Full Text] [Related]

  • 5. Successful treatment of dialysis osteomalacia and dementia, using desferrioxamine infusions and oral 1-alpha hydroxycholecalciferol.
    Hood SA, Clark WF, Hodsman AB, Bolton CF, Cordy PE, Anderson C, Leung F.
    Am J Nephrol; 1984 Dec; 4(6):369-74. PubMed ID: 6517116
    [Abstract] [Full Text] [Related]

  • 6. [A case of iron and aluminum related osteomalacia in a long-term hemodialysis patient].
    Yamagata K, Kobayashi M, Koyama A, Narita M, Amagai H, Ohno A, Yoshikawa S.
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):437-42. PubMed ID: 1875564
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of dialysis osteomalacia with desferrioxamine.
    Brown DJ, Dawborn JK, Ham KN, Xipell JM.
    Lancet; 1982 Aug 14; 2(8294):343-5. PubMed ID: 6124756
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of discontinuation of aluminum exposure on aluminum-induced osteomalacia.
    Finch JL, Bergfeld M, Martin KJ, Chan YL, Teitelbaum S, Slatopolsky E.
    Kidney Int; 1986 Sep 14; 30(3):318-24. PubMed ID: 3784278
    [Abstract] [Full Text] [Related]

  • 14. Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.
    Tielemans C, Collart F, Wens R, Smeyers-Verbeeke J, van Hooff I, Dratwa M, Verbeelen D.
    Clin Nephrol; 1985 Nov 14; 24(5):237-41. PubMed ID: 4075595
    [Abstract] [Full Text] [Related]

  • 15. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
    Milliner DS, Hercz G, Miller JH, Shinaberger JH, Nissenson AR, Coburn JW.
    Kidney Int Suppl; 1986 Feb 14; 18():S100-3. PubMed ID: 3457984
    [No Abstract] [Full Text] [Related]

  • 16. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
    Visser WJ, Van de Vyver FL.
    Clin Nephrol; 1985 Feb 14; 24 Suppl 1():S30-6. PubMed ID: 3915958
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
    Cournot-Witmer G, Gagnadoux MF, Lebon P, Broyer M, Balsan S.
    Arch Fr Pediatr; 1982 Dec 14; 39 Suppl 2():749-54. PubMed ID: 6762177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.